Cost-Effectiveness Model of Cytomegalovirus Management Strategies in Renal Transplantation: Comparing Valaciclovir Prophylaxis with Current Practice
Year of publication: |
2000
|
---|---|
Authors: | Mauskopf, Josephine A. ; Richter, Anke ; Annemans, Lieven ; Maclaine, Grant |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 18.2000, 3, p. 239-251
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Antivirals | Cost effectiveness | Cytomegalovirus infections | Ganciclovir | Nucleosides | Pharmacoeconomics | Valaciclovir |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Incremental Cost Effectiveness of Prophylaxis for Cytomegalovirus Disease in Patients with AIDS
Kempen, John H., (2001)
-
Economic Evaluation of Systemic Treatments for Cytomegalovirus Retinitis in Patients with AIDS
Lee, Todd A., (2001)
-
Rachlis, Anita, (1999)
- More ...
-
A Monte Carlo Simulation for Modelling Outcomes of AIDS Treatment Regimens
Richter, Anke, (2002)
-
Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
Brett Hauber, A., (2000)
-
The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK
Benedict, Ágnes, (2010)
- More ...